This is the authors' abstract. We don't add key points for this paper.
The experimental paradigm was feasible and acceptable. Donepezil did not significantly reduce the incidence of delirium or length of hospital stay, however for both outcomes there was a consistent trend suggesting possible benefit. The sample size required for a definitive trial (99% power, alpha 0.05) would be 95 subjects per arm.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sampson et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: